DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vws6jn/personalized) has announced the addition of the "Personalized Medicine and Companion Diagnostic Market Q3 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment" report to their offering.
'Personalized Medicine and Companion Diagnostic Market Q3 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment' is a cutting-edge comprehensive report on the personalized medicine industry and its impact on the health system. This report tackles the growing market interest in pharmacogenomics, companion diagnostics and the associated market environment.
Individualized, targeted or personalized medicine aims to increase the efficacy of therapeutics via genetic testing and companion diagnostics. Personalized therapeutics and associated companion diagnostics will be more specific and effective thereby giving pharma/biotech companies a significant advantage to recuperate R&D costs. Personalized medicine will reduce the frequency of adverse drug reactions and therefore have a dramatic impact on health economics. Developmental and diagnostic companies will benefit from lower discovery and commercialization costs and more specific market subtypes.
This report describes the current technologies that are propelling the personalized medicine and companion diagnostic market. It examines the current genetic diagnostic tests and companion diagnostic assays that are in use by the medical and pharmaceutical industry today. Current developments in personalized medicine and the pharmacogenomics revolution are discussed. The emerging trends that appear in key markets such as the US, UK, Germany and France are elucidated and analyzed. This study reveals market figures of the overall personalized medicine market and also sub-market figures. Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry.
The study also provides a comprehensive financial and product review of key players in the personalized medicine industry. Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.
In summary, the personalized medicine and associated companion diagnostic market have huge opportunities for growth. This industry will revolutionize the healthcare system and will improve therapeutic effectiveness and reduce the severity of adverse effects. It has enormous potential for investment and the emergence of genetic-based in vitro diagnostics.
Key Topics Covered:
Executive Summary
Introduction
Personalized Medicine Therapeutics and Companion Diagnostics
Personalized Medicine and Integration into the Healthcare System
Private and Public Funding and Personalized Medicine Reimbursement
European Personalized Medicine Market - Payments and Investment
Personalized Medicine -Business Model Analysis
Personalized Medicine Main Industry Players
Personalized Medicine Industry Products and Kits
Personalized Medicine Market Analysis
Strengths and Advantages of Personalized Medicine
Restraints of the Personalized Medicine Market
Personalized Medicine and Regulatory Policies
Final Summary and Future Perspectives
List of Tables
List of Figures
Companies Mentioned
- 23andMe
- Affymetrix
- Astex Pharmaceuticals
- Atossa Genetics
- CuraGen
- Celera Corporation (Quest Diagnostics)
- Celldex Therapeutics
- deCode Genetics (Amgen)
- Illumina
- Genelex
- Myriad
- Nodality
- Qiagen
For more information visit http://www.researchandmarkets.com/research/vws6jn/personalized
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
